KG Petrochem (531609)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Stock trades at ₹216.75 versus book value of ₹340, a meaningful 36% discount to book.
• Latest quarter still shows ₹54 Cr in sales, so the business has not entirely stopped operating.
• Market cap is small at ₹119 Cr, leaving room for operational recovery to have a large per-share impact.
• ROCE of 5.29% is low but positive, indicating some capital is still being deployed productively.

Concerns

• Sales growth is deeply negative at -48.63%, and profit growth has collapsed by -98.92%.
• Latest quarter net profit is effectively zero, yet P/E stands at 42.58, making the earnings multiple meaningless.
• Piotroski F-Score is only 3/9, indicating very weak financial fundamentals.
• No dividend is paid, so shareholders get no income while waiting for a turnaround.

AI Analysis

I have to begin with the obvious: at ₹216.75, this stock sells at roughly two-thirds of its ₹340 book value. Benjamin Graham would smile at a low price-to-book ratio, but he would quickly ask whether the rupees inside the business are earning anything. They are not. ROE is just 1.52% and ROCE is 5.29% — returns on capital are far below what a good textile business should generate. Sales have collapsed 48.63% and profit has fallen 98.92%. The latest quarter shows ₹54 Cr of sales and zero net profit. A P/E of 42.58 is meaningless when earnings are this close to zero; it is a distress valuation, not a growth multiple. I do not see a moat here. Commodity textile products rarely enjoy pricing power, and a Piotroski F-Score of 3/9 confirms weak fundamentals: poor profitability, deteriorating health, and possible red flags in the balance sheet. We are not given debt/equity, promoter holding, or a detailed breakdown of assets, so the quality of the book value is unknown. ₹340 per share is only worth ₹340 if the assets are productive or can be converted to cash without loss. Otherwise, today's discount can become tomorrow's permanent impairment. That said, the downside appears cushioned if the reported book value is genuine. There is no dividend to wait for, and the stock has already ranged between ₹182 and ₹284. This is a potential asset play, not a normal compounder. I would need evidence of asset strength — and a reason for the sales halving — before acting. If the business fails to improve, a low price-to-book ratio is no excuse for a bad bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer